Savara
SVRA
#6249
Rank
S$1.21 B
Marketcap
S$5.50
Share price
-18.23%
Change (1 day)
-14.48%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -S$0.18 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.18 Billion17.07%
2025 -S$0.16 Billion23.94%
2024 -S$0.13 Billion75.29%
2023 -S$70.57 Million43.38%
2022 -S$49.22 Million-11.31%
2021 -S$55.49 Million-13.3%
2020 -S$64.01 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$88.65 Million105.54%
2017 -S$43.13 Million34.11%
2016 -S$32.16 Million-37.43%
2015 -S$51.4 Million38.81%
2014 -S$37.03 Million33.62%
2013 -S$27.71 Million38.49%
2012 -S$20.01 Million24.59%
2011 -S$16.06 Million-36.5%
2010 -S$25.29 Million-3.14%
2009 -S$26.12 Million-23.28%
2008 -S$34.04 Million8.52%
2007 -S$31.37 Million-34.14%
2006 -S$47.63 Million184.43%
2005 -S$16.75 Million90.75%
2004 -S$8.78 Million190.35%
2003 -S$3.03 Million11.64%
2002 -S$2.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.43 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA